nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—SLCO1B1—Methotrexate—esophageal cancer	0.081	0.646	CbGbCtD
Repaglinide—ALB—Methotrexate—esophageal cancer	0.0444	0.354	CbGbCtD
Repaglinide—Myocardial ischaemia—Capecitabine—esophageal cancer	0.00395	0.0243	CcSEcCtD
Repaglinide—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00346	0.0213	CcSEcCtD
Repaglinide—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00345	0.0212	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00323	0.0199	CcSEcCtD
Repaglinide—Pancreatitis—Cisplatin—esophageal cancer	0.00265	0.0163	CcSEcCtD
Repaglinide—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00264	0.0162	CcSEcCtD
Repaglinide—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00255	0.0157	CcSEcCtD
Repaglinide—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.0025	0.0154	CcSEcCtD
Repaglinide—Vasculitis—Methotrexate—esophageal cancer	0.00242	0.0149	CcSEcCtD
Repaglinide—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00238	0.0146	CcSEcCtD
Repaglinide—Myocardial infarction—Cisplatin—esophageal cancer	0.00236	0.0145	CcSEcCtD
Repaglinide—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00228	0.014	CcSEcCtD
Repaglinide—Visual impairment—Cisplatin—esophageal cancer	0.00209	0.0128	CcSEcCtD
Repaglinide—Eye disorder—Cisplatin—esophageal cancer	0.00202	0.0124	CcSEcCtD
Repaglinide—Cardiac disorder—Cisplatin—esophageal cancer	0.00201	0.0124	CcSEcCtD
Repaglinide—Immune system disorder—Cisplatin—esophageal cancer	0.00195	0.012	CcSEcCtD
Repaglinide—Angina pectoris—Capecitabine—esophageal cancer	0.00194	0.0119	CcSEcCtD
Repaglinide—Arrhythmia—Cisplatin—esophageal cancer	0.00193	0.0119	CcSEcCtD
Repaglinide—Bronchitis—Capecitabine—esophageal cancer	0.00192	0.0118	CcSEcCtD
Repaglinide—Alopecia—Cisplatin—esophageal cancer	0.00191	0.0118	CcSEcCtD
Repaglinide—Malnutrition—Cisplatin—esophageal cancer	0.00188	0.0116	CcSEcCtD
Repaglinide—Erythema—Cisplatin—esophageal cancer	0.00188	0.0116	CcSEcCtD
Repaglinide—Visual disturbance—Methotrexate—esophageal cancer	0.00181	0.0111	CcSEcCtD
Repaglinide—Hyperglycaemia—Capecitabine—esophageal cancer	0.0018	0.0111	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00177	0.0109	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00176	0.0108	CcSEcCtD
Repaglinide—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00175	0.0108	CcSEcCtD
Repaglinide—Myocardial infarction—Capecitabine—esophageal cancer	0.00174	0.0107	CcSEcCtD
Repaglinide—Jaundice—Capecitabine—esophageal cancer	0.00173	0.0107	CcSEcCtD
Repaglinide—Urinary tract infection—Capecitabine—esophageal cancer	0.00173	0.0106	CcSEcCtD
Repaglinide—Leukopenia—Cisplatin—esophageal cancer	0.00169	0.0104	CcSEcCtD
Repaglinide—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00168	0.0103	CcSEcCtD
Repaglinide—Rhinitis—Capecitabine—esophageal cancer	0.0016	0.00984	CcSEcCtD
Repaglinide—Hepatitis—Capecitabine—esophageal cancer	0.0016	0.00982	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00159	0.0098	CcSEcCtD
Repaglinide—Oedema peripheral—Capecitabine—esophageal cancer	0.00157	0.00967	CcSEcCtD
Repaglinide—Oedema—Cisplatin—esophageal cancer	0.00154	0.00946	CcSEcCtD
Repaglinide—Anaphylactic shock—Cisplatin—esophageal cancer	0.00154	0.00946	CcSEcCtD
Repaglinide—Visual impairment—Capecitabine—esophageal cancer	0.00154	0.00946	CcSEcCtD
Repaglinide—Erythema multiforme—Capecitabine—esophageal cancer	0.00151	0.00928	CcSEcCtD
Repaglinide—Thrombocytopenia—Cisplatin—esophageal cancer	0.00151	0.00927	CcSEcCtD
Repaglinide—Skin disorder—Cisplatin—esophageal cancer	0.00149	0.00919	CcSEcCtD
Repaglinide—Eye disorder—Capecitabine—esophageal cancer	0.00149	0.00918	CcSEcCtD
Repaglinide—Cardiac disorder—Capecitabine—esophageal cancer	0.00148	0.00911	CcSEcCtD
Repaglinide—Pancreatitis—Methotrexate—esophageal cancer	0.00145	0.00895	CcSEcCtD
Repaglinide—Immune system disorder—Capecitabine—esophageal cancer	0.00144	0.00887	CcSEcCtD
Repaglinide—Arrhythmia—Capecitabine—esophageal cancer	0.00142	0.00877	CcSEcCtD
Repaglinide—Alopecia—Capecitabine—esophageal cancer	0.00141	0.00868	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.0014	0.00862	CcSEcCtD
Repaglinide—Erythema—Capecitabine—esophageal cancer	0.00139	0.00855	CcSEcCtD
Repaglinide—Malnutrition—Capecitabine—esophageal cancer	0.00139	0.00855	CcSEcCtD
Repaglinide—Paraesthesia—Cisplatin—esophageal cancer	0.00138	0.0085	CcSEcCtD
Repaglinide—Back pain—Capecitabine—esophageal cancer	0.00134	0.00827	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00133	0.00817	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00131	0.00807	CcSEcCtD
Repaglinide—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00125	0.0077	CcSEcCtD
Repaglinide—Leukopenia—Capecitabine—esophageal cancer	0.00124	0.00765	CcSEcCtD
Repaglinide—Palpitations—Capecitabine—esophageal cancer	0.00123	0.00755	CcSEcCtD
Repaglinide—Hypertension—Capecitabine—esophageal cancer	0.0012	0.00738	CcSEcCtD
Repaglinide—Hepatitis—Methotrexate—esophageal cancer	0.00119	0.00731	CcSEcCtD
Repaglinide—Arthralgia—Capecitabine—esophageal cancer	0.00118	0.00728	CcSEcCtD
Repaglinide—Chest pain—Capecitabine—esophageal cancer	0.00118	0.00728	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00117	0.00723	CcSEcCtD
Repaglinide—Visual impairment—Methotrexate—esophageal cancer	0.00114	0.00704	CcSEcCtD
Repaglinide—Oedema—Capecitabine—esophageal cancer	0.00113	0.00698	CcSEcCtD
Repaglinide—Hypersensitivity—Cisplatin—esophageal cancer	0.00113	0.00697	CcSEcCtD
Repaglinide—Erythema multiforme—Methotrexate—esophageal cancer	0.00112	0.00691	CcSEcCtD
Repaglinide—Eye disorder—Methotrexate—esophageal cancer	0.00111	0.00683	CcSEcCtD
Repaglinide—Thrombocytopenia—Capecitabine—esophageal cancer	0.00111	0.00683	CcSEcCtD
Repaglinide—Cardiac disorder—Methotrexate—esophageal cancer	0.0011	0.00678	CcSEcCtD
Repaglinide—Skin disorder—Capecitabine—esophageal cancer	0.0011	0.00678	CcSEcCtD
Repaglinide—Immune system disorder—Methotrexate—esophageal cancer	0.00107	0.0066	CcSEcCtD
Repaglinide—Diarrhoea—Cisplatin—esophageal cancer	0.00105	0.00648	CcSEcCtD
Repaglinide—Alopecia—Methotrexate—esophageal cancer	0.00105	0.00646	CcSEcCtD
Repaglinide—Erythema—Methotrexate—esophageal cancer	0.00103	0.00636	CcSEcCtD
Repaglinide—Malnutrition—Methotrexate—esophageal cancer	0.00103	0.00636	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00103	0.00636	CcSEcCtD
Repaglinide—Paraesthesia—Capecitabine—esophageal cancer	0.00102	0.00626	CcSEcCtD
Repaglinide—Back pain—Methotrexate—esophageal cancer	0.001	0.00616	CcSEcCtD
Repaglinide—Dyspepsia—Capecitabine—esophageal cancer	0.000998	0.00614	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000978	0.00602	CcSEcCtD
Repaglinide—Vomiting—Cisplatin—esophageal cancer	0.000977	0.00602	CcSEcCtD
Repaglinide—Rash—Cisplatin—esophageal cancer	0.000969	0.00597	CcSEcCtD
Repaglinide—Constipation—Capecitabine—esophageal cancer	0.000969	0.00597	CcSEcCtD
Repaglinide—Dermatitis—Cisplatin—esophageal cancer	0.000968	0.00596	CcSEcCtD
Repaglinide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000927	0.0057	CcSEcCtD
Repaglinide—Leukopenia—Methotrexate—esophageal cancer	0.000925	0.0057	CcSEcCtD
Repaglinide—Nausea—Cisplatin—esophageal cancer	0.000913	0.00562	CcSEcCtD
Repaglinide—Urticaria—Capecitabine—esophageal cancer	0.0009	0.00554	CcSEcCtD
Repaglinide—Abdominal pain—Capecitabine—esophageal cancer	0.000896	0.00551	CcSEcCtD
Repaglinide—Arthralgia—Methotrexate—esophageal cancer	0.00088	0.00542	CcSEcCtD
Repaglinide—Chest pain—Methotrexate—esophageal cancer	0.00088	0.00542	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000874	0.00538	CcSEcCtD
Repaglinide—Anaphylactic shock—Methotrexate—esophageal cancer	0.000844	0.00519	CcSEcCtD
Repaglinide—Hypersensitivity—Capecitabine—esophageal cancer	0.000835	0.00514	CcSEcCtD
Repaglinide—Thrombocytopenia—Methotrexate—esophageal cancer	0.000826	0.00508	CcSEcCtD
Repaglinide—Skin disorder—Methotrexate—esophageal cancer	0.000819	0.00504	CcSEcCtD
Repaglinide—Pruritus—Capecitabine—esophageal cancer	0.000802	0.00494	CcSEcCtD
Repaglinide—Diarrhoea—Capecitabine—esophageal cancer	0.000775	0.00477	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000769	0.00473	CcSEcCtD
Repaglinide—Paraesthesia—Methotrexate—esophageal cancer	0.000758	0.00466	CcSEcCtD
Repaglinide—Dyspepsia—Methotrexate—esophageal cancer	0.000743	0.00457	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000728	0.00448	CcSEcCtD
Repaglinide—Vomiting—Capecitabine—esophageal cancer	0.000721	0.00444	CcSEcCtD
Repaglinide—Rash—Capecitabine—esophageal cancer	0.000715	0.0044	CcSEcCtD
Repaglinide—Dermatitis—Capecitabine—esophageal cancer	0.000714	0.00439	CcSEcCtD
Repaglinide—Headache—Capecitabine—esophageal cancer	0.00071	0.00437	CcSEcCtD
Repaglinide—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00069	0.00425	CcSEcCtD
Repaglinide—Nausea—Capecitabine—esophageal cancer	0.000673	0.00414	CcSEcCtD
Repaglinide—Urticaria—Methotrexate—esophageal cancer	0.00067	0.00413	CcSEcCtD
Repaglinide—Abdominal pain—Methotrexate—esophageal cancer	0.000667	0.00411	CcSEcCtD
Repaglinide—Hypersensitivity—Methotrexate—esophageal cancer	0.000622	0.00383	CcSEcCtD
Repaglinide—Pruritus—Methotrexate—esophageal cancer	0.000597	0.00367	CcSEcCtD
Repaglinide—Diarrhoea—Methotrexate—esophageal cancer	0.000577	0.00355	CcSEcCtD
Repaglinide—Vomiting—Methotrexate—esophageal cancer	0.000536	0.0033	CcSEcCtD
Repaglinide—Rash—Methotrexate—esophageal cancer	0.000532	0.00327	CcSEcCtD
Repaglinide—Dermatitis—Methotrexate—esophageal cancer	0.000531	0.00327	CcSEcCtD
Repaglinide—Headache—Methotrexate—esophageal cancer	0.000529	0.00325	CcSEcCtD
Repaglinide—Nausea—Methotrexate—esophageal cancer	0.000501	0.00308	CcSEcCtD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000456	0.000641	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000454	0.000637	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GSTT1—esophageal cancer	0.000449	0.000631	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALOX15—esophageal cancer	0.000449	0.000631	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ADH7—esophageal cancer	0.000445	0.000625	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PLCE1—esophageal cancer	0.000445	0.000625	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP2A6—esophageal cancer	0.000444	0.000624	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000442	0.000621	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00044	0.000618	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CFL1—esophageal cancer	0.000439	0.000616	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS1—esophageal cancer	0.000434	0.00061	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ENO1—esophageal cancer	0.000434	0.00061	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000434	0.000609	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000429	0.000603	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—KDR—esophageal cancer	0.000429	0.000602	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSTO1—esophageal cancer	0.000428	0.000602	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—TPI1—esophageal cancer	0.000428	0.000602	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PSME1—esophageal cancer	0.000428	0.000601	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PSME2—esophageal cancer	0.000428	0.000601	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ENO1—esophageal cancer	0.000421	0.000591	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS1—esophageal cancer	0.000421	0.000591	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MET—esophageal cancer	0.00042	0.000589	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PSME1—esophageal cancer	0.000415	0.000583	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PSME2—esophageal cancer	0.000415	0.000583	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—GNG7—esophageal cancer	0.000414	0.000581	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALDOB—esophageal cancer	0.000411	0.000577	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—NOTCH1—esophageal cancer	0.000404	0.000567	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TP53—esophageal cancer	0.000402	0.000564	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000398	0.000559	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000396	0.000556	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GAPDH—esophageal cancer	0.000395	0.000555	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000395	0.000554	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PSME2—esophageal cancer	0.000394	0.000554	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PSME1—esophageal cancer	0.000394	0.000554	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CRABP1—esophageal cancer	0.000392	0.00055	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ADH1B—esophageal cancer	0.00039	0.000548	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000389	0.000546	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000382	0.000536	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000376	0.000528	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TYMP—esophageal cancer	0.000373	0.000524	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GNG7—esophageal cancer	0.000373	0.000523	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NOTCH3—esophageal cancer	0.000372	0.000523	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000371	0.000521	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CYP1B1—esophageal cancer	0.000369	0.000519	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—TP53—esophageal cancer	0.000367	0.000515	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000366	0.000515	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—CREBBP—esophageal cancer	0.000366	0.000514	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP26A1—esophageal cancer	0.000363	0.00051	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP1B1—esophageal cancer	0.000358	0.000503	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000358	0.000503	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—BLVRB—esophageal cancer	0.000354	0.000497	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC52A3—esophageal cancer	0.000354	0.000497	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALOX15—esophageal cancer	0.000354	0.000497	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000353	0.000496	CbGpPWpGaD
Repaglinide—ALB—Metabolism—BLVRB—esophageal cancer	0.000352	0.000494	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC52A3—esophageal cancer	0.000352	0.000494	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALDH2—esophageal cancer	0.000349	0.00049	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000349	0.000489	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CYP19A1—esophageal cancer	0.000347	0.000488	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTO1—esophageal cancer	0.000337	0.000474	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TPI1—esophageal cancer	0.000337	0.000474	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—HSPA5—esophageal cancer	0.000337	0.000473	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP19A1—esophageal cancer	0.000337	0.000473	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NOTCH2—esophageal cancer	0.000334	0.000469	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSTT1—esophageal cancer	0.000332	0.000466	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP2A6—esophageal cancer	0.000328	0.000461	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000327	0.000459	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALDOB—esophageal cancer	0.000323	0.000454	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—HMOX1—esophageal cancer	0.000317	0.000445	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000316	0.000444	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000314	0.000442	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GAPDH—esophageal cancer	0.000311	0.000437	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ENO1—esophageal cancer	0.000311	0.000437	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS1—esophageal cancer	0.000311	0.000437	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CRABP1—esophageal cancer	0.000309	0.000433	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—HMOX1—esophageal cancer	0.000307	0.000431	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PSME2—esophageal cancer	0.000307	0.000431	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PSME1—esophageal cancer	0.000307	0.000431	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—ERBB2—esophageal cancer	0.000307	0.000431	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ABCB1—esophageal cancer	0.000304	0.000427	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CA1—esophageal cancer	0.000301	0.000422	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC10A2—esophageal cancer	0.000301	0.000422	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CA1—esophageal cancer	0.000299	0.00042	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC10A2—esophageal cancer	0.000299	0.00042	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ABCB1—esophageal cancer	0.000295	0.000414	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GNG7—esophageal cancer	0.000293	0.000412	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SMAD4—esophageal cancer	0.00028	0.000394	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CA2—esophageal cancer	0.000275	0.000386	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALDH2—esophageal cancer	0.000275	0.000386	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CA2—esophageal cancer	0.000274	0.000384	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000269	0.000378	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000268	0.000376	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000267	0.000375	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP1B1—esophageal cancer	0.000265	0.000372	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTT1—esophageal cancer	0.000262	0.000367	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP2A6—esophageal cancer	0.000259	0.000363	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000258	0.000362	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PLCE1—esophageal cancer	0.000256	0.000359	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ADH7—esophageal cancer	0.000256	0.000359	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PLCE1—esophageal cancer	0.000254	0.000357	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ADH7—esophageal cancer	0.000254	0.000357	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000253	0.000355	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000251	0.000353	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—ABL1—esophageal cancer	0.00025	0.000351	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—EP300—esophageal cancer	0.000249	0.00035	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP19A1—esophageal cancer	0.000249	0.000349	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS1—esophageal cancer	0.000245	0.000344	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ENO1—esophageal cancer	0.000245	0.000344	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000245	0.000344	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PSME1—esophageal cancer	0.000242	0.000339	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PSME2—esophageal cancer	0.000242	0.000339	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—MYC—esophageal cancer	0.000231	0.000324	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—HMOX1—esophageal cancer	0.000227	0.000319	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ADH1B—esophageal cancer	0.000224	0.000315	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ADH1B—esophageal cancer	0.000223	0.000313	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000223	0.000313	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000218	0.000306	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ABCB1—esophageal cancer	0.000218	0.000306	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TYMP—esophageal cancer	0.000214	0.000301	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TYMP—esophageal cancer	0.000213	0.000299	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—EGFR—esophageal cancer	0.000213	0.000299	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000211	0.000296	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000209	0.000294	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP26A1—esophageal cancer	0.000209	0.000293	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP1B1—esophageal cancer	0.000208	0.000293	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP26A1—esophageal cancer	0.000207	0.000291	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NOTCH1—esophageal cancer	0.000207	0.00029	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CREBBP—esophageal cancer	0.000203	0.000285	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALOX15—esophageal cancer	0.000203	0.000285	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALOX15—esophageal cancer	0.000202	0.000284	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CREBBP—esophageal cancer	0.000197	0.000277	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP19A1—esophageal cancer	0.000196	0.000275	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTO1—esophageal cancer	0.000194	0.000272	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TPI1—esophageal cancer	0.000194	0.000272	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTO1—esophageal cancer	0.000193	0.000271	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TPI1—esophageal cancer	0.000193	0.000271	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.00019	0.000267	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.00019	0.000267	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—CREBBP—esophageal cancer	0.000187	0.000263	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALDOB—esophageal cancer	0.000186	0.000261	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALDOB—esophageal cancer	0.000185	0.000259	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—NOS3—esophageal cancer	0.000182	0.000256	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS2—esophageal cancer	0.00018	0.000253	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GAPDH—esophageal cancer	0.000179	0.000251	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—HMOX1—esophageal cancer	0.000179	0.000251	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GAPDH—esophageal cancer	0.000178	0.00025	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CRABP1—esophageal cancer	0.000177	0.000249	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—NOS3—esophageal cancer	0.000176	0.000248	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CRABP1—esophageal cancer	0.000176	0.000248	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000175	0.000246	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ABCB1—esophageal cancer	0.000172	0.000241	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GNG7—esophageal cancer	0.000169	0.000237	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GNG7—esophageal cancer	0.000168	0.000235	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS2—esophageal cancer	0.000166	0.000234	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000165	0.000231	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CREBBP—esophageal cancer	0.000162	0.000227	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CA1—esophageal cancer	0.000161	0.000227	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000161	0.000227	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS2—esophageal cancer	0.000161	0.000227	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALDH2—esophageal cancer	0.000158	0.000222	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000158	0.000222	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALDH2—esophageal cancer	0.000157	0.000221	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTT1—esophageal cancer	0.00015	0.000211	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTT1—esophageal cancer	0.000149	0.00021	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP2A6—esophageal cancer	0.000149	0.000209	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000148	0.000208	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP2A6—esophageal cancer	0.000148	0.000207	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CA2—esophageal cancer	0.000148	0.000207	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000147	0.000207	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CREBBP—esophageal cancer	0.000146	0.000205	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS3—esophageal cancer	0.000145	0.000203	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS1—esophageal cancer	0.000141	0.000198	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ENO1—esophageal cancer	0.000141	0.000198	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS1—esophageal cancer	0.00014	0.000197	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ENO1—esophageal cancer	0.00014	0.000197	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.00014	0.000196	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PSME1—esophageal cancer	0.000139	0.000195	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PSME2—esophageal cancer	0.000139	0.000195	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—EP300—esophageal cancer	0.000138	0.000194	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PSME1—esophageal cancer	0.000138	0.000194	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PSME2—esophageal cancer	0.000138	0.000194	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000137	0.000193	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000137	0.000193	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—EP300—esophageal cancer	0.000134	0.000188	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—NOS3—esophageal cancer	0.00013	0.000183	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.00013	0.000182	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000121	0.00017	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000121	0.000169	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.00012	0.000169	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP1B1—esophageal cancer	0.00012	0.000168	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—esophageal cancer	0.000119	0.000167	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP1B1—esophageal cancer	0.000119	0.000167	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TYMP—esophageal cancer	0.000115	0.000162	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CREBBP—esophageal cancer	0.000115	0.000161	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP19A1—esophageal cancer	0.000113	0.000158	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP19A1—esophageal cancer	0.000112	0.000157	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	0.000112	0.000157	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MYC—esophageal cancer	0.000111	0.000156	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—EP300—esophageal cancer	0.00011	0.000155	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALOX15—esophageal cancer	0.000109	0.000153	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTO1—esophageal cancer	0.000104	0.000146	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TPI1—esophageal cancer	0.000104	0.000146	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HMOX1—esophageal cancer	0.000103	0.000144	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—NOS3—esophageal cancer	0.000103	0.000144	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CA—esophageal cancer	0.000102	0.000144	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HMOX1—esophageal cancer	0.000102	0.000143	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000101	0.000142	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.0001	0.000141	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALDOB—esophageal cancer	9.98e-05	0.00014	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CA—esophageal cancer	9.93e-05	0.000139	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—EP300—esophageal cancer	9.92e-05	0.000139	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ABCB1—esophageal cancer	9.86e-05	0.000138	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ABCB1—esophageal cancer	9.81e-05	0.000138	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GAPDH—esophageal cancer	9.6e-05	0.000135	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CRABP1—esophageal cancer	9.52e-05	0.000134	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—esophageal cancer	9.39e-05	0.000132	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GNG7—esophageal cancer	9.05e-05	0.000127	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALDH2—esophageal cancer	8.48e-05	0.000119	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CA—esophageal cancer	8.14e-05	0.000114	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTT1—esophageal cancer	8.07e-05	0.000113	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	7.97e-05	0.000112	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TP53—esophageal cancer	7.88e-05	0.000111	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—EP300—esophageal cancer	7.81e-05	0.00011	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS1—esophageal cancer	7.56e-05	0.000106	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ENO1—esophageal cancer	7.56e-05	0.000106	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.46e-05	0.000105	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PSME2—esophageal cancer	7.45e-05	0.000105	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PSME1—esophageal cancer	7.45e-05	0.000105	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.41e-05	0.000104	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CA—esophageal cancer	7.34e-05	0.000103	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CREBBP—esophageal cancer	6.59e-05	9.25e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CREBBP—esophageal cancer	6.55e-05	9.2e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	6.43e-05	9.03e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	6.04e-05	8.49e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NOS3—esophageal cancer	5.9e-05	8.29e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NOS3—esophageal cancer	5.87e-05	8.24e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	5.78e-05	8.11e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HMOX1—esophageal cancer	5.52e-05	7.74e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—esophageal cancer	5.4e-05	7.58e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—esophageal cancer	5.37e-05	7.54e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.29e-05	7.43e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—EP300—esophageal cancer	4.49e-05	6.3e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—EP300—esophageal cancer	4.46e-05	6.27e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.54e-05	4.97e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CA—esophageal cancer	3.32e-05	4.66e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CA—esophageal cancer	3.3e-05	4.64e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NOS3—esophageal cancer	3.17e-05	4.45e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.9e-05	4.07e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—EP300—esophageal cancer	2.41e-05	3.38e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.78e-05	2.5e-05	CbGpPWpGaD
